05.06.2024 15:06:09 - dpa-AFX: *AMGEN'S UPLIZNA SHOWS PROMISE IN PHASE 3 TRIAL FOR IMMUNOGLOBULIN G4-RELATED DISEASE

Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX
Name WKN Börse Kurs Datum/Zeit Diff. Diff. % Geld Brief Erster Schluss
Amgen 867900 NASDAQ 333,480 29.07.24 20:59:00 -1,370 -0,41% 333,420 333,540 334,560 334,850

© 2000-2024 DZ BANK AG. Bitte beachten Sie die Nutzungsbedingungen | Impressum
2024 Infront Financial Technology GmbH